Antibodies to human IL-1β

Details Antibodies to human IL-1β Antibodies to human IL-1β

2001-08-20

2008-11-04

Kemmerer, Elizabeth C. (Department: 1646)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

Blood proteins or globulins, e.g., proteoglycans, platelet...

C530S387900, C530S388100, C530S388150, C530S388230

Reexamination Certificate

active

07446175

ABSTRACT:
An IL-1β binding molecule, in particular an antibody to human IL-1β, especially a human antibody to human IL-1β is provided, wherein the CDRs of the heavy and light chains having amino acid sequences as defined, for use in the treatment of an IL-1 mediated disease or disorder, e.g. osteoarthritis, osteoporosis and other inflammatory arthritides.

REFERENCES:
patent: 4935343 (1990-06-01), Allison et al.
patent: 5348858 (1994-09-01), Uetsuki et al.
patent: 5545806 (1996-08-01), Lonberg et al.
patent: 5569825 (1996-10-01), Lonberg et al.
patent: 5625126 (1997-04-01), Lonberg et al.
patent: 5633425 (1997-05-01), Lonberg et al.
patent: 5661016 (1997-08-01), Lonberg et al.
patent: 5770429 (1998-06-01), Lonberg et al.
patent: 6309636 (2001-10-01), do Couto et al.
patent: 0 267 611 (1988-05-01), None
patent: 0 364 778 (1990-04-01), None
patent: 0 256 055 (1991-08-01), None
patent: 0 323 997 (1993-04-01), None
patent: 0267611 (1993-05-01), None
patent: 0 338 841 (1995-03-01), None
patent: 0 438 474 (1996-05-01), None
patent: 0 463 151 (1996-06-01), None
patent: 0 546 073 (1997-09-01), None
patent: WO 88/01649 (1988-03-01), None
patent: WO 90/07861 (1990-07-01), None
patent: WO 95/01997 (1995-01-01), None
Cacia et al., Biochemidtry, 1996, vol. 35, pp. 1897-1903.
Rudikoff et al., Proc. Natl. Acad. Sci, USA, 1982, vol. 79:1979-1983.
Alberts et al., The Cell, 2002, Garland Science, 4th edition, esp. pp. 161, Fig. 3-42.
Straubinger et al., “Two Unusual Human Immunoglobulin V Kappa Genes”, Biol Chem, Hoppe-Seyler 369, vol. 7, pp. 601-607, (1988).
Jackson et al., “In Vitro Antibody Maturation—Improvement of a High Affinity, Neutralizing Antibody Against IL-1β”, Journal of Immunology, vol. 154, No. 7, pp. 3310-3319, (1995). [XP-000941315].
International Search Report, Apr. 2002.
British Search Report, Jan. 2001.
D'Ettorre et al., “Functional epitope mapping of human interleukin-1β by surface plasmon resonance”, Eur. Cytokine Netw., vol. 8, No. 2, pp. 161-171, (1997).
Massone et al., “Mapping of biologically relevant sites on Human IL-1β using monoclonal antibodies”, The Journal of Immunology, vol. 140, No. 11, pp. 3812-3816, (1988).
Ward et al., “Binding activities of a repertoire of single immunoglobulin variable domains secreted fromEscherichia coli”, Nature, vol. 341, pp. 544-546, (1989).
Muyldermans et al., “Recognition of antigens by single-domain antibody fragments: the superfluous luxury of paired domains”, Trends in Bioghemical Sciences, vol. 26, No. 4, pp. 230-235.
Van den Beucken et al., “Building Novel Binding Ligands to B7.1 and B7.2 Based on Human Antibody Single Variable Light Chain Domains”, J. Mol. Biol., vol. 310, pp. 591-601, (2001).

Affiliated with

Also associated with

Rating

Antibodies to human IL-1β does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antibodies to human IL-1β, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies to human IL-1β will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4040852